Pancragen
Khavinson pancreatic bioregulator
Pancragen is a Khavinson short-peptide bioregulator (Lys-Glu-Asp-Trp / KEDW) originally isolated from pancreatic tissue extracts in Russian gerontology research. It has been studied in animal and cell-culture models for islet-cell function, glucose-handling parameters, and pancreatic tissue ageing, alongside other organ-targeted Khavinson tetrapeptides such as Livagen (liver) and Cortagen (cerebral cortex). Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.
Also known as: Pancreatic bioregulator, KEDW
Cost-per-dose recalculates as you adjust the calculator above.
Pancragen · 20mg
| Vendor | Grade | Risk | Price | $/mg | Trend | $/dose at 0.25 mg | Stock | |
|---|---|---|---|---|---|---|---|---|
| Modified Aminos US | B- | Watch | $59.99 ◎ Best $/mg | $3.00 | $0.75 | In stock | Buy with code → | |
| Core Peptides US | A | Operational | $63.00 ▲ 5.0% | $3.15 | $0.79 | In stock | Visit → | |
| BioLongevity Labs US | B | Operational | $94.97 ▲ 58.3% | $4.75 | $1.19 | In stock | Visit → |
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.